Clinical Trial

General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery

Study acronym: PLEDGE
Recruiting
View on ClinicalTrials.gov →
Summary
In partnership with Helmsley Charitable Trust, the Sanford PLEDGE Study is a large-scale, observational, feasibility study of general population screening for T1D and celiac autoantibodies. Screening is incorporated into routine health care visits within an integrated health system.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-07-17; most recent amendment 2026-02-26.
Status change: Enrolling by Invitation → Recruiting 2020-10-23
Trial Details
NCT Number NCT04477928
Lead Sponsor Sanford Health
Collaborators: The Leona M. and Harry B. Helmsley Charitable Trust, Pacific Northwest Research Institute, University of Exeter
Conditions Type 1 Diabetes, Celiac Disease
Enrollment 33,000 participants
Start Date 2020-07-17
Primary Completion 2031-03 (estimated)
Study Completion 2031-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-02